Biopsy from Recurrent Lesion May Change Further Treatment Plan in Metastatic Breast Cancer

Altundag Kadri

首页> 外文期刊>nuclear medicine and molecular imaging >Biopsy from Recurrent Lesion May Change Further Treatment Plan in Metastatic Breast Cancer

【24h】

Biopsy from Recurrent Lesion May Change Further Treatment Plan in Metastatic Breast Cancer

机译：复发性病变活检可能会改变转移性乳腺癌的进一步治疗计划

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《nuclear medicine and molecular imaging》 |2017年第2期|197-197|共1页
作者
Altundag Kadri;
展开▼
作者单位

MKA Breast Canc Clin;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词

相似文献

外文文献
中文文献

1. Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?" [J] . den Brok Wendie D., Speers Caroline H., Gondara LovedeepBaxter EmilyTyldesley Scott K.Lohrisch Caroline A. Breast cancer research and treatment. . 2017,第2期

机译：Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"
2. Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival? [J] . Altundag Kadri Breast cancer research and treatment. . 2017,第2期

机译：Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?
3. Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients [J] . Yang Yu-Feng, Liao Ying-Yang, Yang MeiPeng Ning-FuXie Shu-RuiXie Yan-Fang Medical oncology . 2014,第10期

机译：Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients
4. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors [O] . Guruprasad Ananda, Susan Mockus, Micaela Lundquist, -1

机译：开发和验证用于检测实体瘤中可临床操作的突变的JAX Cancer Treatment Profile™
5. Inhibitors Of Hypoxia-inducible Factor 1 Block Breast Cancer Metastatic Niche Formation And Lung Metastasis [O] . Chen, J, Chaturvedi, P, Hubbi, ME, 2012

机译：Inhibitors Of Hypoxia-inducible Factor 1 Block Breast Cancer metastatic Niche Formation and Lung metastasis
6. Cyclin D1, Anchorage-Independent Growth and Breast Cancer. [R] . Welsh, C. 2001

机译：Cyclin D1，anchorage-Independent Growth和Breast Cancer。

Biopsy from Recurrent Lesion May Change Further Treatment Plan in Metastatic Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅